期刊文献+

Th17细胞和调节性T细胞与白血病的研究进展 被引量:2

Advances on T helper 17 cells/regulatory T cells and leukemia
原文传递
导出
摘要 T辅助性17(Thelper17,Th17)细胞和调节性T细胞(regulatoryTcell,Treg)的分化过程与功能相互对抗,在白血病的发病、治疗及预后中发挥不同的作用。大多数白血病患者Thl7细胞和Treg细胞的功能增强和(或)数量增加,Th17细胞主要功能是促进炎症反应,提高机体对白血病细胞的防御能力;Treg细胞主要介导免疫抑制和免疫耐受,抑制机体对白血病细胞的免疫反应,降低疗效。Th17细胞和Treg细胞与白血病的发病、治疗、预后等关系密切,人们有望通过干预初始T细胞的分化方向达到治疗白血病的作用。 T helper 17(Th17) cells and regulatory T(Treg) cells are resistant to each other in their functions and differentiation pathways. Thl7 cells and Treg cells play different roles in the development, treatment and prognosis of leukemia. Their functions are stronger and (or) numbers are more increasing than in the healthy controls. Thl7 cells mainly function to promote inflammation and improve the body's defense capability to leukemic cells. Treg cells mainly mediate immune suppression and immune tolerance, and then inhibit the body's immune response to leukemia cells, which can results in poor treatment outcomes. Both Thl7 cells and Treg cells have close relationships with the development, treatment and prognosis of leukemia. We would deal with the leukemia through the intervention of naive T cell differentiation.
出处 《国际儿科学杂志》 2012年第1期88-91,共4页 International Journal of Pediatrics
关键词 T辅助性17细胞 调节性T细胞 白血病 T helpert7 cell Regulatory T cell Leukemia
  • 相关文献

参考文献25

  • 1Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med,2005,201 (2) :233-240.
  • 2王敏(综述),王宁玲,王会平(审校).Th17细胞研究进展[J].国际儿科学杂志,2011,38(2):181-185. 被引量:10
  • 3Bettelli E, Carder Y, Gao W, et al. Reciprocal developmental path- ways for the generation of pathogenic effector TH17 and regulatory T cells. Nature,2006,441 (7090) :235-238.
  • 4Kom T,Bettelli E,Gao W,et al. IL-21 initiates an alternative path- way to induce proinflammatory T (H) 17 cells. Nature, 2007,448 (7152) :484-487.
  • 5Park J, Gao W, Whiston R, et al. Modulation of CD4 + T Lympho- cyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cyto-kine Delivery. Mol Pharm, 2011,8 ( 1 ) : 143-152.
  • 6McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol,2006,27 ( 1 ) :17-23.
  • 7Morgan ME,van Bilsen JH,Bakker AM,et al. Expression of FOXP3 mRNA is not confined to CD4 ~ CD25 + T regulatory cells in humans. Hum Irnmuno1,2005,66 ( 1 ) : 13-20.
  • 8Shenghui Z, Yixiang H, Jianbo W, et al. Elevated frequencies of CD4 ( + ) CD25 ( + ) CD127 (lo) regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer, 2011,129(6) :1373-1381.
  • 9Szczepanski M J, Szajnik M, Czystowska M, et al. Increased frequency and suppression by regulatory T Cells in patients with acute myelogenous leukemia. Clin Cancer Res ,2009,15 ( 10 ) :3325-3332.
  • 10Chang JS, Zhou M, Buffler PA, et al. Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev ,2011,20( 8 ) : 1736-1740.

二级参考文献60

  • 1Veldhoen M,Hocking RJ,Atkins CJ,et al.TGF-β in the context of an inflammatory cytokine milieu supports denovo differentiation of IL-17-producing T cells.Immunity,2006,24:179-189.
  • 2Bettlli E,Carrier Y,Gao W,et al.Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.Nature,2006,441:235-238.
  • 3Beyer M,Schultze JL.Regulatory T cells in cancer.Blood,2006,108:804-811.
  • 4Wang X,Zheng J,Liu J,et al.Increased population of CD4^+ CD25^+ regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.Eur J Haematol,2005,75:468-476.
  • 5Harrington LE,Hatton RD,Mangan PR,et al.lnterleukin 17-producing CD4^+ efector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol,2005,6:1123-1132.
  • 6Bettelli E,Korn T,Kuchroo VK.Th17:the third member of the effector T cell trilogy.Curr Opin Immuno1,2007,19:1-6.
  • 7Manel N,Unutmaz D,Littman DR.The differentiation of human Th17 cells requires trans forming growth factor-beta and induction of the nuclear receptor RORgammat.Nat Immunol,2008,9:641-649.
  • 8Numasaki M,Watanabe M,Suzuki T,et al.IL-17 enhances the net aagiogenic activity and in vivo growth of human non-small cell lung cancer in SCD mice through promoting CXCR-2-dependent angiogenesis.lmmunol,2005,175:6177-6189.
  • 9Zhang B,Rong G,Wei H,et al.The prevalence of Th17 cells in patients with gastric cancer.Bioehem Biophys Res Commun,2008,374:533-537.
  • 10Gogas H,Ioannovich J,Dafni U,et al.Prognostic significance of autoimmunity during treatment of melanoma with interferon.N Engl J Med,2006,354:709-718.

共引文献39

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部